Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 11 - 20 of 240 results for "Pharmaceutical"

Trump's tariff implications for Australian investors

ANDREW MCKEAN  |  WEDNESDAY, 5 FEB 2025
US President Donald Trump has imposed a 25% tariff on imports from Canada and Mexico, and a 10% tariff on China, with the latter already in effect while the others have been delayed by one month, subject to border and drug conditions - what does this ...

Partners Group promotes local staffers

ELIZABETH FRY  |  THURSDAY, 16 JAN 2025
Partners Group co-head of private debt for Asia has been promoted to senior investment leader of the firm's private market royalties business. Sydney-based Krish Vaswani has been with the global private market asset management firm since 2016 and ...

Nuveen extends private credit fund to Australian investors

ELIZA BAVIN  |  TUESDAY, 3 DEC 2024
Nuveen has extended access to its private capital platform to Australian wholesale investors via the launch of the Nuveen Churchill Private Credit Income Fund. Nuveen said the fund has already secured early investment from a range of Australian wealth ...

ART, ISPT to build $585m Sydney life sciences hub

JAMIE WILLIAMSON  |  THURSDAY, 28 NOV 2024
... education Jason Lourensz said. "The last few years have demonstrated why world-leading healthcare, research and pharmaceutical spaces are an absolute necessity, underpinning our desire to deliver more state-of-the-art healthcare facilities that can be ...

BlackRock partners to build $1.5bn life sciences platform

MATTHEW WAI  |  FRIDAY, 1 NOV 2024
BlackRock and Wentworth Capital have joined forces to acquire two life sciences seed assets as part of a plan to build a $1.5 billion platform. BlackRock, through its real estate division, and Wentworth Capital have acquired two assets in Sydney to ...

Chief financial officer roles 'widely ambiguous': Research

ELIZA BAVIN  |  TUESDAY, 6 AUG 2024
... range of industry settings in both the profit and not-for-profit sectors, including mining, education, healthcare, pharmaceutical and financial services, and professional services, over an 18-month period to explore the role expectations, conflicts and ...

QIC invests in Australian biotech start-up

ELIZA BAVIN  |  MONDAY, 8 JUL 2024
... allows scientists to grow microscopic representations of human tissue to eliminate the need for animal testing in pharmaceutical drug development. A $2.2 million pre-seed round led by early-stage investor Jelix Ventures alongside QIC and Angelloop will ...

Where does the world's largest active manager say to invest?

ANDREW MCKEAN  |  FRIDAY, 21 JUN 2024
... approach has gained approval for use against certain blood cancers that previously had few treatment options. The top pharmaceutical companies worldwide by the number of drugs in their research and development pipeline are Roche (194), Novartis (191) ...

Industry Super Australia names new chair

ELIZABETH FRY  |  WEDNESDAY, 19 JUN 2024
... Management. In the non-financial services sectors, he worked on several campaigns for BP Australia, and leading pharmaceutical brands. "It's a privilege to be involved in the great work that we do as a collective. I'm proud of the world-class ...

Budget 2024: Cost of living relief takes centre stage

ELIZA BAVIN  |  TUESDAY, 14 MAY 2024
... medicines. As part of the agreement, instead of rising with inflation, there will be a one-year freeze on the maximum Pharmaceutical Benefits Scheme (PBS) patient co-payment for everyone with a Medicare card and a five-year freeze for pensioners and ...